
Hyerix
An AI-native desktop GUI for managing NATS infrastructure locally.

Product memo
Backend engineers and SREs running NATS infrastructure use it to manage their clusters. This local-first desktop GUI handles scheduling work, replacing scattered tools and complex CLI commands. It includes an AI-native interface for JetStream, KV, and Object Store management, alongside real-time metrics and anomaly detection. Signal AI allows plain-English queries, with all data processing handled locally to ensure privacy.
- For who
- Backend engineers and SREs running NATS
- Solves what
- Provides an AI-native desktop GUI for managing NATS infrastructure.
- Local-first desktop GUI
- AI-powered cluster insights
- Real-time monitoring & anomaly detection
In their own words
The AI-native NATS GUI for JetStream, KV, and cluster ops.
Built for backend engineers and SREs running NATS in production. Inspect streams, debug consumers, validate configs — without CLI archaeology.
The AI-native desktop GUI for NATS. Manage JetStream, browse KV and Object Stores, and ask Signal AI why your cluster is misbehaving — in plain English.
About Hyerix Expand
Hyerix provides a specialized AI-native desktop GUI for backend engineers and SREs who manage NATS infrastructure. It simplifies complex cluster operations, offering a local-first approach that ensures data privacy by processing all information on the user's machine.
The tool includes features for managing JetStream, KV, and Object Stores, alongside real-time metrics and anomaly detection. Its unique Signal AI allows users to query cluster behavior in plain English, reducing the need for extensive CLI knowledge and simplifying troubleshooting workflows for NATS operators.
Niche context
Adjacent niches
Competitive context
5 peers · Same primary niche.
Commercial cues
- Model
- subscription
- Free tier
- Yes
- Trial
- 14 days
Pricing strategy
- • A free tier for two machines removes adoption friction for individual users.
- • An Enterprise plan with custom pricing handles larger team deployments.
- • 14-day trial lowers adoption risk.

